| Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis. | |
| | |
MedLine Citation:
|
PMID: 17661091 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We describe a child presenting with oligoclonal plasma IgM (1.2 g%) and nephrotic syndrome with focal segmental glomerulosclerosis. Oligoclonality was demonstrated by the analysis of the complementary determining region 3 (CDR 3) on immunoglobulin heavy chains and by two dimensional electrophoresis and Western blot analysis that showed the bulk of isoforms having a cationic muU chain compared with the normal homologue (pI 7.5 vs 6.5). Urinary light chains were absent, and bone marrow aspirate was normal. Usual therapies for nephrotic syndrome with steroids and cyclosporin were useless. At the age of 9 years the patient was treated with plasmapheresis plus cyclophosphamide (2 mg/kg per day for 60 days), which temporarily reduced plasma IgM, and proteinuria was normal for 3 years. After this period, due to new recurrence of nephrotic syndrome, the patient received a cycle with anti-CD20 antibodies (500 mg/m(2) every week for a month) associated with a cycle of plasmapheresis that normalized proteinuria again, and, after 3 years, the proteinuria is still in remission. This is the first case of nephrotic syndrome associated with oligoclonal plasma IgM and mesangial IgM deposits. Both cyclophosphamide and anti-CD20 antibodies associated with plasmapheresis induced, at different stages, stable and protracted remission of proteinuria without evident side effects. Long term efficacy and safety of the association are still to be determined. |
| | |
Authors:
|
Gian Marco Ghiggeri; Luca Musante; Giovanni Candiano; Maurizio Bruschi; Laura Santucci; Giancarlo Barbano; Antonella Trivelli; Lucia Rivabella; Rosanna Gusmano; Francesco Perfumo |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't Date: 2007-07-28 |
Journal Detail:
|
Title: Pediatric nephrology (Berlin, Germany) Volume: 22 ISSN: 0931-041X ISO Abbreviation: Pediatr. Nephrol. Publication Date: 2007 Nov |
Date Detail:
|
Created Date: 2007-10-01 Completed Date: 2007-12-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8708728 Medline TA: Pediatr Nephrol Country: Germany |
Other Details:
|
Languages: eng Pagination: 1953-6 Citation Subset: IM |
Affiliation:
|
Department of Nephrology, G. Gaslini Children's Hospital, Genoa, Italy. labnefro@ospedale-gaslini.ge.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal
/
administration & dosage* Child Combined Modality Therapy Cyclophosphamide / administration & dosage* Glomerulonephritis / drug therapy, immunology Glomerulosclerosis, Focal Segmental / drug therapy, immunology Humans Immunologic Factors / administration & dosage* Immunosuppressive Agents / administration & dosage* Male Nephrotic Syndrome / drug therapy, immunology Oligoclonal Bands / blood* Plasmapheresis* Proteinuria / drug therapy*, immunology Remission Induction |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Immunologic Factors; 0/Immunosuppressive Agents; 0/Oligoclonal Bands; 0/rituximab; 50-18-0/Cyclophosphamide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Magneto-controlled bioelectronics for the antigen-antibody interaction based on magnetic-core/gold-s...
Next Document: Teaching molecular genetics: chapter 4-positional cloning of genetic disorders.